| about |

Fluid is a Stanford University spinout company that enables users to track and diagnose influenza and other infectious disease using their mobile phone.  Fluid's technology combines user-collected information with large healthcare datasets to create personalized risk assessments.

The current explosion of public health data represents a turning point in health information.  However, in its current form, much of this data is inaccessible to everyday people.  Fluid's platform combines personalized, user-collected data with real-time public information on infectious disease to improve awareness, enhance behavior, and enable more people to benefit from clinical treatment.

| who we are |

Adam is an entrepreneur focused     on technology and business development in mobile health.

Previously at Google X and Harvard, he is inventor on nine patents and author of ten publications on point-of-care diagnostics. Adam co-developed the core technologies of Claros Diagnostics (acquired by Opko in 2011) and nonprofit Diagnostics-For-All, which raised $10 M from the Bill & Melinda Gates Foundation.

Micah is a Stanford professor whose research spans mobile healthcare, big data, consumer electronics, and enterprise software.

He is the founding investor in new companies which have raised more than $70 M in follow-on financing. Most recently, Micah has been a seed-stage investor and adviser to BioImagene (acquired in 2010 by Roche for $100 M in cash), Stack Exchange, Hadapt, and Judicata.

Adam Siegel

Micah Siegel

| contact |

fluid, inc. 

615 grant avenue, third floor 

san francisco, ca 94133 


©  2015

Please correct the following errors: